UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000042997
Receipt No. R000049091
Scientific Title The effect of energy surplus combined with protein supplement on muscle protein synthesis rate.
Date of disclosure of the study information 2021/01/13
Last modified on 2021/01/13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The effect of energy surplus combined with protein supplement on muscle protein synthesis rate.
Acronym Energy surplus and muscle protein synthesis rate.
Scientific Title The effect of energy surplus combined with protein supplement on muscle protein synthesis rate.
Scientific Title:Acronym Energy surplus and muscle protein synthesis rate
Region
Japan

Condition
Condition Healthy subjects
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To examine the effect of energy surplus on muscle protein synthesis rate.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Myofibrillar protein synthesis rate.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Dose comparison
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 One week consumption of additional protein intake (energy requirement*0.1kcal) following weight maintenance standard meal consumption for 1 week.
Interventions/Control_2 One week consumption of additional protein and carbohydrate intake (energy requirement*0.1kcal and energy requirement*0.3kcal respectively) following weight maintenance standard meal consumption for 1 week.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
45 years-old >=
Gender Male
Key inclusion criteria 1) Individuals who understand the purpose and contents of the study, have ability to provide written consent, and give the written informed consent form
2) Healthy men whose age 20 to 45 years old
3) Who do not have exercise training more than 20 hours per week.
Key exclusion criteria 1) Who have severe or progressive disorder
2) Who have history of digestive surgery
3) Who have medical history in kidney
4) Diabetes, impaired glucose tolerance patients
5) Constant use of medicine which influence the metabolism
6) Who drink a lot of alcohol(60g/day)
7) Whose eating habits are extremely irregular
8) Who participate or are willing to participate clinical trials of other food products, drugs, or beauty products.
9) Who are allergic to milk.
10) Constant user of protein or amino acids supplements
11) Who are judged as unsuitable for the study by the principal investigator for other reasons
Target sample size 24

Research contact person
Name of lead principal investigator
1st name Kentaro
Middle name
Last name Kawanaka
Organization Fukuoka University
Division name Faculty of Sports and Health Science
Zip code 8140180
Address 8-19-1, Nanakuma, Jonan-ku, Fukuoka City, Fukuoka, 814-0180, Japan
TEL 0928716631(6720)
Email kawanaka@fukuoka-u.ac.jp

Public contact
Name of contact person
1st name Kentaro
Middle name
Last name Kawanaka
Organization Fukuoka University
Division name Fukuoka University
Zip code 8140180
Address 8-19-1, Nanakuma, Jonan-ku, Fukuoka City, Fukuoka, 814-0180, Japan
TEL 0928716631(6720)
Homepage URL http://www.fuipa.spo.fukuoka-u.ac.jp/
Email kawanaka@fukuoka-u.ac.jp

Sponsor
Institute Fukuoka University
Institute
Department

Funding Source
Organization JSPS KAKENHI
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization same as above
Address 8-19-1, Nanakuma, Jonan-ku, Fukuoka City, Fukuoka, 814-0180, Japan
Tel 0928716631
Email fumed-ethics@fukuoka-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 福岡大学スポーツ科学部(福岡)
基盤研究機関身体活動研究所
Fukuoka University in Faculty of Sports and Health Science
Central Research Institute for Physical Activity

Other administrative information
Date of disclosure of the study information
2021 Year 01 Month 13 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2020 Year 12 Month 25 Day
Date of IRB
2020 Year 12 Month 25 Day
Anticipated trial start date
2021 Year 01 Month 13 Day
Last follow-up date
2025 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 01 Month 13 Day
Last modified on
2021 Year 01 Month 13 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049091

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.